Compassionate use of experimental therapies: who should decide?

por Zettler, Patricia J
Publicado 2015

Regulating drug promotion to promote the public health: a response to Bennett et al.

por Zettler, Patricia J.
Publicado 2015

Is it ‘gene therapy’?

por Sherkow, Jacob S, Zettler, Patricia J, Greely, Henry T
Publicado 2018

Mifepristone, preemption, and public health federalism

por Zettler, Patricia J, Beckmeyer, Annamarie, Brown, Beatrice L, Sarpatwari, Ameet
Publicado 2022

The promise of direct-to-consumer COVID-19 testing: ethical and regulatory issues

por Kalokairinou, Louiza, Zettler, Patricia J, Nagappan, Ashwini, Kyweluk, Moira A, Wexler, Anna
Publicado 2020

Regulatory flexibility for COVID-19 research

por Fernandez Lynch, Holly, Dickert, Neal W, Zettler, Patricia J, Joffe, Steven, Largent, Emily A
Publicado 2020

The stem cell market and policy options: a call for clarity

por Zarzeczny, Amy, Atkins, Harold, Illes, Judy, Kimmelman, Jonathan, Master, Zubin, Robillard, Julie M, Snyder, Jeremy, Turner, Leigh, Zettler, Patricia J, Caulfield, Timothy
Publicado 2018

ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update

por Lovell-Badge, Robin, Anthony, Eric, Barker, Roger A., Bubela, Tania, Brivanlou, Ali H., Carpenter, Melissa, Charo, R. Alta, Clark, Amander, Clayton, Ellen, Cong, Yali, Daley, George Q., Fu, Jianping, Fujita, Misao, Greenfield, Andy, Goldman, Steve A., Hill, Lori, Hyun, Insoo, Isasi, Rosario, Kahn, Jeffrey, Kato, Kazuto, Kim, Jin-Soo, Kimmelman, Jonathan, Knoblich, Jürgen A., Mathews, Debra, Montserrat, Nuria, Mosher, Jack, Munsie, Megan, Nakauchi, Hiromitsu, Naldini, Luigi, Naughton, Gail, Niakan, Kathy, Ogbogu, Ubaka, Pedersen, Roger, Rivron, Nicolas, Rooke, Heather, Rossant, Janet, Round, Jeff, Saitou, Mitinori, Sipp, Douglas, Steffann, Julie, Sugarman, Jeremy, Surani, Azim, Takahashi, Jun, Tang, Fuchou, Turner, Leigh, Zettler, Patricia J., Zhai, Xiaomei
Publicado 2021